Chemokine-like factor 1 is a functional ligand for CC chemokine receptor 4 (CCR4)

被引:62
|
作者
Wang, Y
Zhang, YM
Yang, X
Han, WL
Liu, YN
Xu, QM
Zhao, R
Di, CH
Song, QS
Ma, DL [1 ]
机构
[1] Peking Univ, Ctr Human Dis Genom, Beijing 100083, Peoples R China
[2] Peking Univ, Hlth Sci Ctr, Sch Basic Med Sci, Lab Med Immunol, Beijing 100083, Peoples R China
关键词
chemokine; CLF; recombinant CKLF1; TARC/CCL17; CCR4; ligand;
D O I
10.1016/j.lfs.2005.05.070
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chemokine-like factor 1 (CKLF1) exhibits chemotactic effects on leukocytes. Its amino acid sequence shares similarity with those of TARC/CCL17 and MDC/CCL22, the cognate ligands for CCR4. The chemotactic effects of CKLF1 for CCR4-transfected cells could be desensitized by TARC/CCL17 and markedly inhibited by PTX. CKLF1 induced a calcium flux in CCR4-transfected cells and fully desensitized a subsequent response to TARC/CCL17, and TARC/CCL17 could partly desensitize the response to CKLF1. CKLF1 caused significant receptor internalization in pCCR4-EGFP transfected cells. Taken together, CKLF1 is a novel functional ligand for CCR4. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:614 / 621
页数:8
相关论文
共 50 条
  • [41] CXC chemokine ligand 4 (CXCL4) down-regulates CC chemokine receptor expression on human monocytes
    Schwartzkopff, Franziska
    Petersen, Frank
    Grimm, Tobias Alexander
    Brandt, Ernst
    INNATE IMMUNITY, 2012, 18 (01) : 124 - 139
  • [42] Results of a Phase 1/2 Study for KW-0761, a Monoclonal Antibody Directed Against CC Chemokine Receptor Type 4 (CCR4), In CTCL Patients
    Duvic, Madeleine
    Pinter-Brown, Lauren
    Foss, Francine M.
    Sokol, Lubomir
    Jorgensen, Jeffrey
    Spitalny, George L.
    Kim, Youn H.
    BLOOD, 2010, 116 (21) : 424 - 424
  • [43] A novel cytomegalovirus-encoded chemokine signals via CC chemokine receptor 1 (CCR 1)
    Schleiss, MR
    Haggerty, S
    Wang, Y
    Miao, ZN
    Penfold, M
    PEDIATRIC RESEARCH, 2003, 53 (04) : 349A - 349A
  • [44] Role of chemokine-like factor 1 as an inflammatory marker in diseases
    Li, Yutong
    Yu, Haiyang
    Feng, Juan
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [45] Chemerin and Chemokine-like Receptor 1 Are Not Prognostic in Colorectal Carcinoma
    Weber, Florian
    Jung, Rudolf
    Treeck, Oliver
    Buechler, Christa
    ANTICANCER RESEARCH, 2023, 43 (02) : 831 - 839
  • [46] Role of Chemokine Receptor CCR4 and Regulatory T Cells in Wound Healing of Diabetic Mice
    Barros, Janaina F.
    Waclawiak, Ingrid
    Pecli, Cyntia
    Borges, Paula A.
    Georgii, Janaina L.
    Ramos-Junior, Erivan S.
    Canetti, Claudio
    Courau, Tristan
    Klatzmann, David
    Kunkel, Steven L.
    Penido, Carmen
    Canto, Fabio B.
    Benjamim, Claudia F.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : 1161 - 1170
  • [47] Chemokine receptors as therapeutic tools in Hodgkin lymphoma: CCR4 and beyond
    Aldinucci, Donatella
    Pinto, Antonio
    Gloghini, Annunziata
    Carbone, Antonino
    BLOOD, 2010, 115 (03) : 746 - 747
  • [48] Antagonists of the chemokine receptor CCR4 reverse the tumor-promoting microenvironment of renal cancer
    Berlato, Chiara
    Kahn, Moddasar N.
    Schioppa, Tiziana
    Thompson, Richard
    Maniati, Eleni
    Canosa, Monica
    Kulbe, Hagen
    Sheldon, Chris
    Wreggett, Keith
    Hagemann, Urs
    Duncan, Alexander
    Fletcher, Laura
    Wilkinson, Robert W.
    Powles, Thomas
    Quezada, Sergio
    Balkwill, Frances
    CANCER RESEARCH, 2014, 74 (19)
  • [49] ATP priming of macrophage-derived chemokine responses in cells expressing the CCR4 receptor
    Rosethorne, EM
    Charlton, SJ
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [50] Two C-terminal peptides of human CKLF1 interact with the chemokine receptor CCR4
    Wang, Ying
    Zhang, Yingmei
    Han, Wenling
    Li, Dan
    Tian, Linjie
    Yin, Caihua
    Ma, Dalong
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2008, 40 (05): : 909 - 919